C4 Therapeutics (CCCC) Retained Earnings (2019 - 2026)
C4 Therapeutics' (CCCC) quarterly Retained Earnings came in at -$322000.0 in Q1 2026, up 99.95% year-on-year from -$161039.3 in Q1 2025, and up 99.96% quarter-over-quarter from -$738.7 million in Q4 2025.
C4 Therapeutics (CCCC) Retained Earnings (2019 - 2026) Analysis & Trends
C4 Therapeutics' Retained Earnings history runs 8 years deep, the most recent figure standing at -$322000.0 for Q1 2026.
- On a quarterly basis, Retained Earnings rose 99.95% year-over-year to -$322000.0 in Q1 2026; TTM through Mar 2026 was -$322000.0, a 99.95% increase from a year earlier, with the FY2025 full-year figure at -$738.7 million, down 16.57% from the prior year.
- Retained Earnings rose to -$322000.0 in Q1 2026 per CCCC's latest filing, from -$738.7 million in the prior quarter.
- Across five years, Retained Earnings topped out at $87000.0 in Q3 2025 and bottomed at -$738.7 million in Q4 2025.
- The 5-year median for Retained Earnings is -$4.6 million (2022), against an average of -$229.9 million.
- Across the five-year window, Retained Earnings slumped 498875.59% in 2024 and jumped 100.01% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$4.1 million in 2022, then surged by 96.93% to -$127000.0 in 2023, then slumped by 498875.59% to -$633.7 million in 2024, then slipped by 16.57% to -$738.7 million in 2025, then soared by 99.96% to -$322000.0 in 2026.
- Per Business Quant, the three latest CCCC Retained Earnings figures stand at -$322000.0 (Q1 2026), -$738.7 million (Q4 2025), and $87000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | C4 Therapeutics | 460.17 Mn | 224.50 Mn | - | -322,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -322,000.00 |
| Dec 31, 2025 | -738.69 Mn |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Mar 31, 2025 | -660.02 Mn |
| Dec 31, 2024 | -633.70 Mn |
| Sep 30, 2024 | -599.13 Mn |
| Jun 30, 2024 | -440,000.00 |
| Mar 31, 2024 | -380,000.00 |
| Dec 31, 2023 | -127,000.00 |
| Sep 30, 2023 | -493.60 Mn |
| Jun 30, 2023 | -466.60 Mn |
| Mar 31, 2023 | -2.47 Mn |
| Dec 31, 2022 | -4.14 Mn |
| Sep 30, 2022 | -5.41 Mn |
| Jun 30, 2022 | -4.58 Mn |
| Mar 31, 2022 | -299.34 Mn |
| Dec 31, 2021 | -775,000.00 |
| Sep 30, 2021 | -252.06 Mn |
| Jun 30, 2021 | -69,000.00 |